ghk-cu avoid wilson's disease Disease: A Comprehensive Review of the Molecular Mechanisms GHK-Cu Dosing: 1.7mg/Day Injectable (2026)
Description
PNB-0408 IUPAC Name (2S,3S)-N-(6-amino-6-oxohexyl)-2-[[(2S)-2-(hexanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanamide Molecular Formula CHNO Molecular Weight 504.67 Purity 99% Pure (LC-MS) Material Safety Data Sheet (MSDS) View Material Safety Data Sheet Liquid Availability 30mL liquid (20mg/mL, 600mg
Total sodium ion excipient (+)
Researchers utilize AOD 9604 as a research material for investigating molecular activity, peptide stability, and controlled cellular processes within experimental models
This product requires aValid prescription
